Yeast or Saccharomyces cerevisiae is a microorganism that has been widely used for decades in many of our daily products such as bread, wine and beer.
However, certain strains of probiotic yeasts have also been shown in numerous clinical trials to have many beneficial effects on our health and especially our gut health. A recent article was dedicated to them by the Observatoire de la santé (article in French). Let’s talk about these strains: Saccharomyces boulardii and S.cerevisiae CNCM I-3856
Saccharomyces boulardii, a trusted probiotic yeasts, globally recognized
Discovered in 1923 by the French microbiologist Henri Boulard, Saccharomyces boulardii has become an essential solution for our digestive health and is today qualified as the most documented probiotic yeast available on the market. With more than 70 clinical studies reporting its beneficial effects on health, S.boulardii is recommended by doctors and gastroenterologists over 65 years and in more than 100 countries. It is used to manage various types of occasional digestive issues, such as antibiotic associated diarrhea, traveler’s and acute diarrhea of children and adults.
A recent published clinical study confirms that our Saccharomyces boulardii strain CNCM I-3799, demonstrates beneficial effects on the reduction and severity of diarrhea in infants and children, aged from 3 to 36 months. With a unique shelf life of 5 years which reinforces the uniqueness and technical superiority of our strain, Saccharomyces boulardii I-3799 becomes your new ally for stable probiotic formulas.
Abdominal pain, bloating, Saccharomyces cerevisiae I-3856, the other probiotic yeast for digestive comfort
Hundreds of thousands of people suffer from recurrent digestive disorders such as abdominal pain, bloating, constipation or diarrhea often resulting in a real impact on their daily quality of life. Several clinical studies confirmed that the use of the strain Saccharomyces cerevisiae CNCM I-3856 allows to significantly reduce abdominal pain and bloating, but also helps to regulate transit disorders, in case of constipation but also diarrhea. In addition, recent findings have demonstrated a significant improvement in quality of life in volunteers who received a daily supplementation of this unique strain.
S. cerevisiae CNCM I-3856 is a probiotic yeast representing a complete solution for gastrointestinal symptoms management and a better quality of life.
DISCOVER ALL OUR LATEST NEWS
Successful Vital Nutrients Symposium:
Shaping the Future of Healthy Aging
The Vital Nutrients Symposium 2025, held in Kassel, Germany, offered an excellent platform to discuss age-related health, emphasizing emphasizing dietary supplements’ role in prolonging healthspan.
Groundbreaking Vitamin K2 Research Presented at the 7th Osteoporosis Congress in Padova (March 19-21, 2025)
Gnosis recently took an important step in advancing the scientific understanding of vitamin K2 by sponsoring the 7th Osteoporosis Congress in Padova, Italy. Supported by the Italian Ministry of Health, this event brought together esteemed experts in nephrology, osteoporosis, and bone health.
Emothion® Webinar Explores the Science for Skin Health
Gnosis by Lesaffre recently hosted a highly informative webinar titled “Emothion® Skin Health Redefined: The Future of Beauty from Within.”
